TLR7/8 agonist 6
TLR7/8 agonist 6 (Compound 4) is the potent agonist of TLR7/8 with IC50s of 0.18 and 5.34 μM, respectively. TLR7/8 agonist 6 is an imidazoquinoline derivative compound. Toll-like receptors (TLRs) 7 and 8 are key targets in the development of immunomodulatory drugs for researching infectious disease, cancer, and autoimmune disorders[1].
Product Specifications
CAS Number
2115702-83-3
UNSPSC
12352005
Target
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tlr7-8-agonist-6.html
Purity
98.93
Solubility
DMSO : 20 mg/mL (ultrasonic; heat to 60°C)
Smiles
CCCCC1=NC2=C(N=C3C=C(C=CC3=C2N1CC4=CC=C(CN)C=C4)C(OC)=O)N
Molecular Formula
C24H27N5O2
Molecular Weight
417.50
References & Citations
[1]Yang M, et al. Toll-like receptor 7 and 8 imidazoquinoline-based agonist/antagonist pairs. Bioorg Med Chem Lett. 2022;59:128548.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF647 conjugate, 0.1mg/mL
![7-Hydroxybenzo[a]pyrene](https://cdn.genprice.uk/products/572/1058855190283/imageurl/trc-h829450-50mg.webp)